Ovoca Bio plc (ISE:OVXA)
Ireland · Delayed Price · Currency is EUR 0.0105
0.00 (0.00%)
Inactive · Last trade price on Jun 4, 2025
Ovoca Bio Company Description
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health.
It’s lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder.
The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Ovoca Bio plc
| Country | Ireland |
| Founded | 1985 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Timothy McCutcheon |
Contact Details
Address: 17 Pembroke Street Upper Dublin, D02 AT22 Ireland | |
| Phone | 353 1 661 9819 |
| Website | ovocabio.com |
Stock Details
| Ticker Symbol | OVXA |
| Exchange | Euronext Dublin |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | IE00B4XVDC01 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Timothy Rand McCutcheon | Chief Executive Officer and Director |
| Leah O'Donovan | Chief Financial Officer |
| Reneta Nikolova | Corporate Secretary |